MikeTrendsTrends right now
AI: reposAPI

search

Adreno

Trends

  1. 1
    EU approves first drug for cerebral adrenoleukodystrophy▼European Commission grants marketing authorization for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral adrenoleukodystrophy (cALD), a rare neurodegenerative disease✉newsWorldEU Politics6 d ago

    The European Commission has granted marketing authorization for NEZGLYAL (leriglitazone), making it the first pharmacological treatment approved for cerebral adrenoleukodystrophy, a rare and rapidly progressive neurodegenerative disease that primarily affects young boys. Until now, care options for cALD were limited mainly to stem cell transplantation in eligible patients. The approval is being highlighted as a significant milestone for families affected by the rare disease and for rare-disease drug development in Europe.

  2. 2
    A closer look at Qualcomm's Adreno X2 GPU●Qualcomm's Adreno X2 GPUYhnTechnologySemiconductors286 d ago

    A detailed technical analysis of Qualcomm's Adreno X2 GPU, the graphics processor in its Snapdragon X2 PC chips, has been published by the hardware analysis site Chips and Cheese. The piece examines the architecture in depth, and the topic is drawing attention among chip enthusiasts and developers following Qualcomm's latest Windows-on-ARM push.

  3. 3
    Qualcomm Expands Support for Open-Source Linux Graphics Drivers▼Qualcomm Continues Doing More For Their Open-Source Linux Graphics Drivers✉newsTechnologySoftware1 d ago

    Qualcomm is continuing to invest in its open-source Linux graphics driver stack, according to Phoronix reporting. The company has been steadily improving its MSM DRM kernel driver and related userspace components to better support its Adreno GPUs on Linux, part of a broader push to move beyond vendor-specific Android drivers toward upstream kernel support. Linux enthusiasts generally welcome these contributions as they improve out-of-the-box graphics support for Snapdragon hardware.

Repos